<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01997593</url>
  </required_header>
  <id_info>
    <org_study_id>20130801</org_study_id>
    <nct_id>NCT01997593</nct_id>
  </id_info>
  <brief_title>Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected</brief_title>
  <official_title>Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ping Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate the analgesic effect of intraperitoneal infiltration of&#xD;
      ropivacaine in children undergoing laparoscopic surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Quality assurance plan that addresses data validation and registry procedures, including&#xD;
           any plans for site monitoring and auditing.&#xD;
&#xD;
        2. Data checks to compare data entered into the registry against predefined rules for range&#xD;
           or consistency with other data fields in the registry.&#xD;
&#xD;
        3. Source data verification to assess the accuracy, completeness, or representativeness of&#xD;
           registry data by comparing the data to external data sources .&#xD;
&#xD;
        4. Data dictionary that contains detailed descriptions of each variable used by the&#xD;
           registry, including the source of the variable, coding information .&#xD;
&#xD;
        5. Standard Operating Procedures to address registry operations and analysis activities,&#xD;
           such as patient recruitment, data collection, data management, data analysis, reporting&#xD;
           for adverse events, and change management.&#xD;
&#xD;
        6. Sample size assessment to specify the number of participants or participant years&#xD;
           necessary to demonstrate an effect.&#xD;
&#xD;
        7. Plan for missing data to address situations where variables are reported as missing,&#xD;
           unavailable, &quot;non-reported,&quot; uninterpretable, or considered missing because of data&#xD;
           inconsistency or out-of-range results&#xD;
&#xD;
        8. Statistical analysis plan describing the analytical principles and statistical&#xD;
           techniques to be employed in order to address the primary and secondary objectives, as&#xD;
           specified in the study protocol or plan&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score</measure>
    <time_frame>within the first 2days after the surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic dose</measure>
    <time_frame>Within the first 2days after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal function recovery score</measure>
    <time_frame>Within the first 2days after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound score</measure>
    <time_frame>Within the first 2days after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Testicular</condition>
  <condition>Colic</condition>
  <arm_group>
    <arm_group_label>ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preincisional wound intraperitoneal infiltration of 1% ropivacaine 0.3ml/kg was performed in group I patients before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intraperitoneal infiltration of ropivacaine</intervention_name>
    <description>intraperitoneal infiltration of ropivacaine by a special equipment</description>
    <arm_group_label>ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Between 6 months and 5years.&#xD;
&#xD;
          2. Laparoscopic inguinal hernia repair&#xD;
&#xD;
          3. Laparoscopic testicular descent fixation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient who are suffering from mental disease&#xD;
&#xD;
          2. Patient who suffering from neuromuscular disease&#xD;
&#xD;
          3. Local anesthetic allergy&#xD;
&#xD;
          4. Patient who needs directly into ICU after the operation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yang Hui, Professor</last_name>
    <role>Study Director</role>
    <affiliation>China Tongji Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>October 27, 2013</study_first_submitted>
  <study_first_submitted_qc>November 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Ping Yang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>pediatric</keyword>
  <keyword>pain</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>ropivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

